Cancer Research

Skin cancer is the most common malignancy in the US, says the American Academy of Dermatology, and one American dies every 62 minutes from melanoma. The WHO estimated that, in the year 2000, up to 71,000 deaths worldwide were attributed to excessive UV exp ...

Article - News Staff - Sep 18 2008 - 1:33am

Squirrels Know A Cure For Cancer

Biologists at the University of Rochester writing in Aging Cell have found that small-bodied rodents with long lifespans have evolved a previously unknown anti-cancer mechanism that appears to be different from any anti-cancer mechanisms employed by human ...

Article - News Staff - Sep 18 2008 - 1:43am

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy For Psoriasis Patients Compared To Interruptin

PARIS, September 18 /PRNewswire/--- Additional Analysis Shows HUMIRA Effectively Treats Adult Patients with Moderate to Severe Psoriasis Regardless of Age, Duration of Disease, Diagnosis of Psoriatic Arthritis or Recent Systemic Therapy More psoriasis pat ...

Article - Anna Ohlden - Sep 18 2008 - 5:31am

Why Does Chemotherapy Only Work Some Of The Time?

MIT researchers have shown that cells from different people don't all react the same way when exposed to the same DNA-damaging agent, a finding that could help clinicians predict how patients will respond to chemotherapy. The research team from MIT&# ...

Article - News Staff - Sep 18 2008 - 6:32pm

Cancer-Causing Gut Bacteria Implicated

There are more bacteria in our bodies than there ever have been people on the Earth. In fact, there are more bacteria in the colon than there are human cells in our bodies. Most of the bacteria in our guts are harmless and many are beneficial to our health ...

Article - News Staff - Sep 21 2008 - 2:32pm

U.S. Company May Have Silver Bullet In Vitamin D Fight Against Disease

WILMINGTON, Massachusetts, September 22 /PRNewswire/-- Xenon Corp., a company internationally recognized as a leader and pioneer in the field of Pulsed Light systems, might have found the silver bullet that researchers have been seeking to increase vitami ...

Article - Anna Ohlden - Sep 21 2008 - 11:31pm

Results From IMPROVE Study Show Therapeutic Effect Of New Formulation Of Rebif(R) At 16 Weeks In Patients With Multiple Sclerosi

GENEVA, Switzerland, September 22 /PRNewswire/--- Study Meets Primary Endpoint by Demonstrating Significant Effect of new Formulation of Rebif(R) on Disease Activity as Measured by MRI After 16 Weeks of Treatment- Data Presented at Late-Breaking Session o ...

Article - Anna Ohlden - Sep 22 2008 - 1:31am

EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation

AMSTERDAM, September 22 /PRNewswire/-- Kiadis Pharma announced today that its lead product ATIR(TM) has been granted orphan drug designation (ODD) by the European Medicines Agency (EMEA) for the prevention of acute Graft versus Host Disease (GvHD) followi ...

Article - Anna Ohlden - Sep 22 2008 - 5:31am

Helix Receives Approval To Open Sites In Germany For Its Ongoing Clinical Trial With Topical Interferon Alpha-2b In Patients Wit

AURORA, Ontario, September 22 /PRNewswire/-- Helix BioPharma announced today that it has received the necessary regulatory approvals to open clinical sites in Germany to expand upon its clinical trial with Topical Interferon Alpha-2b in patients with ano- ...

Article - Anna Ohlden - Sep 22 2008 - 7:31am

Why We Will Always Have Cancer

In today's world, humans are at the top of the food chain. We have almost no natural predators as there are few animals that rely on humans as prey. Pathogens are the only exception. Viruses, bacteria, parasites and other classes of infectious agents ...

Blog Post - Erin Richards - Nov 17 2008 - 12:15pm